This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Trials in Progress
    • Trials in Progress
      • ARAMON Trial
      • ARASEC Trial
      • ARASTEP Trial
      • ECLIPSE Trial
      • Oral EPI-7386
      • SPLASH Trial
    • Right Side
      • PCCTC
        • DORA
        • IRONMAN
        • PROMISE
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Suprapubic Catheter
        Diane K. Newman, DNP FAAN BCB-PMD
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Education
      • Covid-19
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Pelvic Health & Reconstruction
      • Endourology
      • Testicular Cancer
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • ASCO 2023
      • AUA 2023
      • ASCO GU 2023
      • EAU 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology

Prostate Cancer

Recent Abstracts
Treatment of the patient with castration-resistant biochemical progression of prostate cancer - Abstract April 2, 2012
Prostate Cancer Etiology April 2, 2012
Prostate Cancer Prognostic Nomograms April 2, 2012
A survey of current clinical practice in permanent and temporary prostate brachytherapy: 2010 Update - Abstract April 2, 2012
Prostate bed motion during intensity-modulated radiotherapy treatment - Abstract April 2, 2012
Competing-risks mortality after radiotherapy vs. observation for localized prostate cancer: A population-based study - Abstract April 2, 2012
Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer - Abstract April 2, 2012
Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate - Abstract April 2, 2012
Prostate Cancer Grading & Staging Systems April 1, 2012
Prostate Cancer Screening April 1, 2012
EAU 2012 - The key role of time in predicting post-radical prostatectomy urinary continence recovery rate: Conditional survival analysis - Session Highlights March 30, 2012
EAU 2012 - Dynamics of the pelvic floor in continent and stress urinary incontinent men after radical prostatectomy: A functional MRI study - Session Highlights March 30, 2012
EAU 2012 - Clinical prognosis and predictive factors of the further recovery of urinary continence in patients who do not achieve continence within 1 year after radical prostatectomy: 42 months follow-up - Session Highlights March 30, 2012
EAU 2012 - Introducing a nurse-led trans-perineal saturation prostate biopsy (TPSBx) service - Session Highlights March 30, 2012
Circulating tumor cells as a marker of response: Implications for determining treatment efficacy and evaluating new agents - Abstract March 30, 2012
Current status of immunological approaches for the treatment of prostate cancer - Abstract March 30, 2012
Tracking target position variability using intraprostatic fiducial markers and electronic portal imaging in prostate cancer radiotherapy - Abstract March 30, 2012
Predictive models for biochemical recurrence of prostate cancer after local treatment. Nomograms - Abstract March 30, 2012
Biochemical recurrence in patients with prostate cancer after radical treatment. Comparative study of prostatectomy vs. radiotherapy - Abstract March 30, 2012
The evolving paradigm of second-line hormonal therapy options for castration-resistant prostate cancer - Abstract March 30, 2012
Page 1176 of 1306
  • Start
  • Prev
  • 1171
  • 1172
  • 1173
  • 1174
  • 1175
  • 1176
  • 1177
  • 1178
  • 1179
  • 1180
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free